| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ... Nature 486 (7403), 346-352, 2012 | 3949 | 2012 |
| Analysis of circulating tumor DNA to monitor metastatic breast cancer SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ... New England Journal of Medicine 368 (13), 1199-1209, 2013 | 1750 | 2013 |
| The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395-399, 2012 | 1714 | 2012 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7 (1), 1-16, 2016 | 770 | 2016 |
| Progesterone receptor modulates ERα action in breast cancer H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ... Nature 523 (7560), 313-317, 2015 | 466 | 2015 |
| Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254, 2017 | 344 | 2017 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 1-6, 2015 | 340 | 2015 |
| Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ... Science translational medicine 4 (157), 157ra143-157ra143, 2012 | 320 | 2012 |
| Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ... Cell reports 3 (2), 342-349, 2013 | 283 | 2013 |
| A new genome‐driven integrated classification of breast cancer and its implications SJ Dawson, OM Rueda, S Aparicio, C Caldas The EMBO journal 32 (5), 617-628, 2013 | 269 | 2013 |
| A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ... Cell 167 (1), 260-274. e22, 2016 | 261 | 2016 |
| Copynumber: efficient algorithms for single-and multi-track copy number segmentation G Nilsen, K Liestøl, P Van Loo, HKM Vollan, MB Eide, OM Rueda, ... BMC genomics 13 (1), 1-16, 2012 | 180 | 2012 |
| TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance L Silwal-Pandit, HKM Vollan, SF Chin, OM Rueda, S McKinney, T Osako, ... Clinical Cancer Research 20 (13), 3569-3580, 2014 | 171 | 2014 |
| Genome-driven integrated classification of breast cancer validated in over 7,500 samples HR Ali, OM Rueda, SF Chin, C Curtis, MJ Dunning, SAJR Aparicio, ... Genome biology 15 (8), 1-14, 2014 | 156 | 2014 |
| JARID1B is a luminal lineage-driving oncogene in breast cancer S Yamamoto, Z Wu, HG Russnes, S Takagi, G Peluffo, C Vaske, X Zhao, ... Cancer cell 25 (6), 762-777, 2014 | 132 | 2014 |
| Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ... Scientific reports 6 (1), 1-13, 2016 | 124 | 2016 |
| Master regulators of FGFR2 signalling and breast cancer risk MNC Fletcher, MAA Castro, X Wang, I De Santiago, M O’Reilly, SF Chin, ... Nature communications 4 (1), 1-12, 2013 | 120 | 2013 |
| ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium DG Holland, A Burleigh, A Git, MA Goldgraben, PA Perez‐Mancera, ... EMBO molecular medicine 3 (3), 167-180, 2011 | 110 | 2011 |
| RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer C Cruz, M Castroviejo-Bermejo, S Gutiérrez-Enríquez, A Llop-Guevara, ... Annals of Oncology 29 (5), 1203-1210, 2018 | 109 | 2018 |
| Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer AA Margolin, E Bilal, E Huang, TC Norman, L Ottestad, BH Mecham, ... Science translational medicine 5 (181), 181re1-181re1, 2013 | 108 | 2013 |
Carlos CaldasUniversity of CambridgeVerified email at cruk.cam.ac.uk
